Updated Jul 16, 2026
PATOU GARY has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $271K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | XENE | Xenon Pharmaceuticals Inc. | S — Open-market sale | 1.3K | $53.14 | $70K |
| 2026-06-04 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise | 2.6K | — | |
| 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | S — Open-market sale | 2.0K | $41.05 | $84K |
| 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 1.0K | $39.80 | $42K |
| 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise | 3.1K | $13.48 | $42K |
| 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | S — Open-market sale | 2.9K | $41.11 | $117K |
| 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 649 | $39.80 | $26K |
| 2024-11-22 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise | 3.5K | $7.38 | $26K |
PATOU GARY is a corporate insider — currently tracked as Insider of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($271K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PATOU GARY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.